sur Hangzhou Diagens Biotechnology (HKG:2526)
The Future of Medical AI Collaboration: Insights from Kevin Kelly and Dr. Ning Song
During the 5th Global Digital Trade Expo in Hangzhou, Diagens Tech hosted Kevin Kelly and Dr. Ning Song to discuss the future of medical AI. Key topics included the shift from single AI models to continuous AI creation and the evolving relationship between clinicians and AI. Kelly emphasized that AI's role in healthcare is inevitable, endorsing tailored AI solutions for clinicians. Dr. Song supported a diverse ecosystem where medical AI enhances various specialties.
The discussion highlighted AI's potential to handle diagnostic tasks, allowing clinicians more time for patient interaction. Kelly noted that AI impacts healthcare by making information accessible, but human empathy remains irreplaceable. Concerns about AI's influence on youth perceptions and their reliance on AI-generated health advice also surfaced.
Both experts acknowledged that while AI simplifies routine tasks, breakthrough innovations still require human creativity. They emphasized the importance of judgment, learning, and perseverance for future professionals working alongside AI. Diagens Tech's iMedLoop™ exemplifies how the company aims to integrate AI into medical practices, fostering a continuous cycle of improvement and adaptation.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Hangzhou Diagens Biotechnology